NCT02870699View on ClinicalTrials.gov

Efficacy of Evonail® Solution in the Prevention of Nail Damage Induced by Docetaxel in Patients With Breast Cancer.

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2016

Conditions
Breast Carcinoma
Interventions
DEVICE

Evonail

film-forming solution containing water Evaux naturally rich in lithium, strontium and manganese with UV filter

DEVICE

Placebo excipient

film forming excipient solution

Trial Locations (1)

54519

Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy

Sponsors

Collaborators (1)

Clinact
All Listed Sponsors
collaborator

Clinact

OTHER

lead

Institut de Cancérologie de Lorraine

OTHER

NCT02870699 - Efficacy of Evonail® Solution in the Prevention of Nail Damage Induced by Docetaxel in Patients With Breast Cancer. | Biotech Hunter | Biotech Hunter